Reference List - Chapter 3: Animal Models of Type 1 Diabetes: Genetics and Immunological Function

(1) Lang J, Bellgrau D. Animal models of type 1 diabetes: genetics and immunological function. Adv Exp Med Biol 2004; 552:91-116.
http://www.ncbi.nlm.nih.gov/pubmed/15622960?ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(2) Nakayama M, Abiru N, Moriyama H, Babaya N, Liu E, Miao D et al. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 2005; 435(7039):220-223.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=15889095
(3) Krishnamurthy B, Mariana L, Gellert SA, Colman PG, Harrison LC, Lew AM et al. Autoimmunity to Both Proinsulin and IGRP Is Required for Diabetes in Nonobese Diabetic 8.3 TCR Transgenic Mice. J Immunol 2008; 180(7):4458-4464.
http://www.ncbi.nlm.nih.gov/pubmed/18354167?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(4) Su MA, Giang K, Zumer K, Jiang H, Oven I, Rinn JL et al. Mechanisms of an autoimmunity syndrome in mice caused by a dominant mutation in Aire. J Clin Invest 2008; 118(5):1712-1726.
http://www.ncbi.nlm.nih.gov/pubmed/18414681?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(5) Chen Z, Herman AE, Matos M, Mathis D, Benoist C. Where CD4+CD25+ T reg cells impinge on autoimmune diabetes. J Exp Med 2005; 202(10):1387-1397.
http://www.ncbi.nlm.nih.gov/pubmed/16301745?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(6) Mordes JP, Bortell R, Blankenhorn EP, Rossini AA, Greiner DL. Rat models of type 1 diabetes: genetics, environment, and autoimmunity. ILAR J 2004; 45(3):278-291.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15229375
(7) Leiter EH. Mice with targeted gene disruptions or gene insertions for diabetes research: problems, pitfalls, and potential solutions. diabetol 2002; 45(3):296-308.
http://www.ncbi.nlm.nih.gov/pubmed/11914735?ordinalpos=7&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(8) Roep BO, Atkinson M, von Herrath M. Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes. Nat Rev Immunol 2004; 4(12):989-997.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15573133
(9) Anderson MS, Bluestone JA. The NOD Mouse: A Model of Immune Dysregulation. Annu Rev Immunol 2004.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15568997
(10) Devendra D, Liu E, Eisenbarth GS. Type 1 diabetes: recent developments. Brit Med J 2004; 328(7442):750-754.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=15044291&query_hl=1&itool=pubmed_docsum
(11) Eisenbarth GS, Gottlieb PA. Autoimmune polyendocrine syndromes. N Engl J Med 2004; 350(20):2068-2079.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=15141045&query_hl=3&itool=pubmed_docsum
(12) Homann D, von Herrath M. Regulatory T cells and type 1 diabetes. Clin Immunol 2004; 112(3):202-209.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15308110
(13) Mathis D, Benoist C. Back to central tolerance. Immunity 2004; 20(5):509-516.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15142520
(14) Panagiotopoulos C, Trudeau JD, Tan R. T-cell epitopes in type 1 diabetes. Curr Diab Rep 2004; 4(2):87-94.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15035967
(15) Polychronakos C. Animal models of spontaneous autoimmune diabetes: notes on their relevance to the human disease. Curr Diab Rep 2004; 4(2):151-154.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15035976
(16) Chatenoud L. CD3-specific antibody-induced active tolerance: from bench to bedside. Nat Rev Immunol 2003; 3(2):123-132.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12563296
(17) Ramsdell F. Foxp3 and natural regulatory T cells: key to a cell lineage? Immunity 2003; 19(2):165-168.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12932350
(18) King M, Pearson T, Shultz LD, Leif J, Bottino R, Trucco M et al. Development of new-generation HU-PBMC-NOD/SCID mice to study human islet alloreactivity. Ann N Y Acad Sci 2007; 1103:90-3. Epub@2007 Mar 21.:90-93.
(19) Pearson T, Greiner DL, Shultz LD. Creation of "humanized" mice to study human immunity. Curr Protoc Immunol 2008; Chapter 15:Unit 15.21.:Unit.
http://www.ncbi.nlm.nih.gov/pubmed/18491294?ordinalpos=8&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(20) Enee E, Martinuzzi E, Blancou P, Bach JM, Mallone R, van Endert P. Equivalent specificity of peripheral blood and islet-infiltrating CD8+ T lymphocytes in spontaneously diabetic HLA-A2 transgenic NOD mice. J Immunol 2008; 180(8):5430-5438.
http://www.ncbi.nlm.nih.gov/pubmed/18390725?ordinalpos=19&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(21) Kasprowicz DJ, Smallwood PS, Tyznik AJ, Ziegler SF. Scurfin (FoxP3) controls T-dependent immune responses in vivo through regulation of CD4+ T cell effector function. J Immunol 2003; 171(3):1216-1223.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12874208
(22) Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ et al. Projection of an immunological self shadow within the thymus by the aire protein. Science 2002; 298(5597):1395-1401.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12376594
(23) Liston A, Lesage S, Wilson J, Peltonen L, Goodnow CC. Aire regulates negative selection of organ-specific T cells. Nat Immunol 2003; 4(4):350-354.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12612579
(24) Yang Y, Santamaria P. Lessons on autoimmune diabetes from animal models. Clin Sci (Lond) 2006; 110(6):627-639.
http://www.ncbi.nlm.nih.gov/pubmed/16689681?ordinalpos=6&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(25) Roep BO. Are insights gained from NOD mice sufficient to guide clinical translation? Another inconvenient truth. Ann N Y Acad Sci 2007; 1103:1-10. Epub@2007 Mar 21.:1-10.
http://www.ncbi.nlm.nih.gov/pubmed/17376838?ordinalpos=31&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(26) Shoda LK, Young DL, Ramanujan S, Whiting CC, Atkinson MA, Bluestone JA et al. A comprehensive review of interventions in the NOD mouse and implications for translation. Immunity 2005; 23(2):115-126.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16111631
(27) Herold KC, Hagopian W, Auger JA, Poumian-Ruiz E, Taylor L, Donaldson D et al. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med 2002; 346(22):1692-1698.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12037148
(28) Effects of Oral Insulin in Relatives of Patients With Type 1 Diabetes: The Diabetes Prevention Trial-Type 1. Diab care 2005; 28(5):1068-1076.
(29) Moriyama H, Abiru N, Paronen J, Sikora K, Liu E, Miao D et al. Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse. Proc Natl Acad Sci U S A 2003; 100(18):10376-10381.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=Abstract&list_uids=12925730
(30) Homann D, Eisenbarth GS. An immunologic homunculus for type 1 diabetes. J Clin Invest 2006; 116(5):1212-1215.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=16670763
(31) Singh B, Delovitch TL. Immune mechanisms that regulate susceptibility to autoimmune type I diabetes. Clin Rev Allergy Immunol 2000; 19(3):247-264.
http://www.ncbi.nlm.nih.gov/pubmed/11138408?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(32) McDevitt H. Closing in on type 1 diabetes. N Engl J Med 2001; 345(14):1060-1061.
PM:11586961
(33) Zhang L, Nakayama M, Eisenbarth GS. Insulin as an autoantigen in NOD/human diabetes. Curr Opin Immunol 2008; .
http://www.ncbi.nlm.nih.gov/pubmed/18178393?ordinalpos=28&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(34) Harrison LC. Vaccination against self to prevent autoimmune disease: the type 1 diabetes model. Immunol Cell Biol 2008; 86(2):139-145.
http://www.ncbi.nlm.nih.gov/pubmed/18180798?ordinalpos=27&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(35) Giarratana N, Penna G, Adorini L. Animal models of spontaneous autoimmune disease: type 1 diabetes in the nonobese diabetic mouse. Methods Mol Biol 2007; 380:285-311.:285-311.
http://www.ncbi.nlm.nih.gov/pubmed/17876100?ordinalpos=17&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(36) Ablamunits V, Sherry NA, Kushner JA, Herold KC. Autoimmunity and beta cell regeneration in mouse and human type 1 diabetes: the peace is not enough. Ann N Y Acad Sci 2007; 1103:19-32. Epub@2007 Mar 21.:19-32.
http://www.ncbi.nlm.nih.gov/pubmed/17376841?ordinalpos=30&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(37) Di Lorenzo TP, Peakman M, Roep BO. Translational mini-review series on type 1 diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes. Clin Exp Immunol 2007; 148(1):1-16.
http://www.ncbi.nlm.nih.gov/pubmed/17349009?ordinalpos=34&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(38) Yang Y, Santamaria P. Lessons on autoimmune diabetes from animal models. Clin Sci (Lond) 2006; 110(6):627-639.
http://www.ncbi.nlm.nih.gov/pubmed/16689681?ordinalpos=54&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(39) Faideau B, Larger E, Lepault F, Carel JC, Boitard C. Role of beta-cells in type 1 diabetes pathogenesis. Diabetes 2005; 54 Suppl 2:S87-96.:S87-S96.
http://www.ncbi.nlm.nih.gov/pubmed/16306346?ordinalpos=70&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(40) Wicker LS, Clark J, Fraser HI, Garner VE, Gonzalez-Munoz A, Healy B et al. Type 1 diabetes genes and pathways shared by humans and NOD mice. J Autoimmun 2005; 25 Suppl:29-33. Epub@2005 Oct 28.:29-33.
http://www.ncbi.nlm.nih.gov/pubmed/16257508?ordinalpos=74&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(41) Suri A, Unanue ER. The Murine Diabetogenic Class II Histocompatibility Molecule I-A(g7): Structural and Functional Properties and Specificity of Peptide Selection. Adv Immunol 2005; 88:235-65.:235-265.
http://www.ncbi.nlm.nih.gov/pubmed/16227092?ordinalpos=76&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(42) Haskins K. Pathogenic T-cell clones in autoimmune diabetes: more lessons from the NOD mouse. Adv Immunol 2005; 87:123-62.:123-162.
http://www.ncbi.nlm.nih.gov/pubmed/16102573?ordinalpos=88&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(43) Chatenoud L, Bach JF. Regulatory T cells in the control of autoimmune diabetes: the case of the NOD mouse. Int Rev Immunol 2005; 24(3-4):247-267.
http://www.ncbi.nlm.nih.gov/pubmed/16036377?ordinalpos=93&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(44) Hussain S, Wagner M, Ly D, Delovitch TL. Role of regulatory invariant CD1d-restricted natural killer T-cells in protection against type 1 diabetes. Immunol Res 2005; 31(3):177-188.
http://www.ncbi.nlm.nih.gov/pubmed/15888910?ordinalpos=99&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(45) Leiter EH. Nonobese diabetic mice and the genetics of diabetes susceptibility. Curr Diab Rep 2005; 5(2):141-148.
http://www.ncbi.nlm.nih.gov/pubmed/15794919?ordinalpos=101&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(46) Anderson MS, Bluestone JA. The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 2005; 23:447-85.:447-485.
http://www.ncbi.nlm.nih.gov/pubmed/15771578?ordinalpos=103&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(47) Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y. Breeding of a non-obese, diabetic strain of mice. Exp Anim 1980; 29:1-13.
(48) Kanazawa Y, Komeda K, Sato S, Mori S, Akanuma K, Takaku F. Non-obese-diabetic mice: immune mechanisms of pancreatic B-cell destruction. diabetol 1984; 27:113-115.
(49) Wicker LS, Miller BJ, Coker LZ, McNally SE, Scott S, Mullen Y et al. Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse. J Exp Med 1987; 165:1639-1654.
(50) Maruyama T, Takei I, Yanagawa T, Takahashi T, Asaba Y, Kataoka K et al. Insulin autoantibodies in non-obese diabetic (NOD) mice and streptozotocin induced diabetic mice. Diabetes Res 1988; 7(2):93-96.
(51) Ziegler AG, Vardi P, Ricker AT, Hattori M, Soeldner JS, Eisenbarth GS. Radioassay determination of insulin autoantibodies in NOD mice. Correlation with increased risk of progression to overt diabetes. diab 1989; 38(3):358-363.
(52) Gottlieb PA, Eisenbarth GS. Mouse and man: multiple genes and multiple autoantigens in the aetiology of type I DM and related autoimmune disorders. J Autoimmun 1996; 9:277-281.
(53) Ott PA, Anderson MR, Tary-Lehmann M, Lehmann PV. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes. Cell Immunol 2005; 235(1):1-11.
http://www.ncbi.nlm.nih.gov/pubmed/16122720?ordinalpos=4&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(54) Todd JA, Aitman TJ, Cornall RJ, Ghosh S, Hall JR, Hearne CM et al. Genetic analysis of autoimmune type I diabetes mellitus in mice. Nature 1991; 351(6327):542-547.
(55) Oldstone MBA. Prevention of type 1 diabetes in nonobese diabetic mice by virus infection. Science 1988; 239:500-502.
(56) Wilberz S, Partke HJ, Dagnaes-Hansen F, Herberg L. Persistent MHV (mouse hepatitis virus) infection reduces the incidence of diabetes mellitus in non-obese diabetic mice. diabetol 1991; 34(1):2-5.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=1647335
(57) Atkinson MA, Leiter EH. The NOD mouse model of type 1 diabetes: as good as it gets? Nat Med 1999; 5(6):601-604.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10371488
(58) Rainbow DB, Esposito L, Howlett SK, Hunter KM, Todd JA, Peterson LB et al. Commonality in the genetic control of Type 1 diabetes in humans and NOD mice: variants of genes in the IL-2 pathway are associated with autoimmune diabetes in both species. Biochem Soc Trans 2008; 36(3):312-315.
http://www.ncbi.nlm.nih.gov/pubmed/18481948?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(59) Hattori M, Buse JB, Jackson RA, Glimcher L, Dorf ME, Minami M et al. The NOD mouse: recessive diabetogenic gene within the major histocompatibility complex. Science 1986; 231(4739):733-735.
(60) Todd JA, Bell JI, McDevitt HO. HLA-DQB gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987; 329(6140):599-604.
(61) Wicker LS, Todd JA, Peterson LB. Genetic control of autoimmune diabetes in the NOD mouse. Ann Rev Immunol 1995; 13:179-200.
(62) Todd JA, Acha-Orbea H, Bell JI, Chao N, Fronek Z, Jacob CO et al. A molecular basis for MHC class II associated autoimmunity. Science 1988; 240(4855):1003-1009.
(63) Lund T, O'Reilly L, Hutchings P, Kanagawa O, Simpson E, Gravely R et al. Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain. Nature 1990; 345(6277):727-729.
(64) Inoue K, Ikegami H, Fujisawa T, Noso S, Nojima K, Babaya N et al. Allelic variation in class I K gene as candidate for a second component of MHC-linked susceptibility to type 1 diabetes in non-obese diabetic mice. diabetol 2004; 47(4):739-747.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15298352
(65) Fujisawa T, Ikegami H, Noso S, Yamaji K, Nojima K, Babaya N et al. MHC-linked susceptibility to type 1 diabetes in the NOD mouse: further localization of Idd16 by subcongenic analysis. Ann N Y Acad Sci 2006; 1079:118-21.:118-121.
http://www.ncbi.nlm.nih.gov/pubmed/17130541?ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(66) Yamaji K, Ikegami H, Fujisawa T, Noso S, Nojima K, Babaya N et al. Contribution of class III MHC to susceptibility to type 1 diabetes in the NOD mouse. Ann N Y Acad Sci 2006; 1079:114-7.:114-117.
http://www.ncbi.nlm.nih.gov/pubmed/17130540?ordinalpos=4&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(67) Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003; 423(6939):506-511.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12724780
(68) Yamanouchi J, Rainbow D, Serra P, Howlett S, Hunter K, Garner VE et al. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat Genet 2007; .
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17277778&query_hl=15&itool=pubmed_docsum
(69) Hamilton-Williams EE, Serreze DV, Charlton B, Johnson EA, Marron MP, Mullbacher A et al. Transgenic rescue implicates beta2-microglobulin as a diabetes susceptibility gene in nonobese diabetic (NOD) mice. Proc Natl Acad Sci U S A 2001; 98(20):11533-11538.
http://www.ncbi.nlm.nih.gov/pubmed/11572996?ordinalpos=12&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(70) Todd JA, Wicker LS. Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models. Immunity 2001; 15(3):387-395.
PM:11567629
(71) Robles DT, Eisenbarth GS, Dailey NJM, Peterson LB, Wicker LS. Insulin autoantibodies are associated with islet inflammation but not always related to diabetes progression in NOD congenic mice. diab 2002; 52(3):882-886.
(72) Encinas JA, Kuchroo VK. Mapping and identification of autoimmunity genes. Curr Opin Immunol 2000; 12(6):691-697.
PM:11102774
(73) McDuffie M. Genetics of autoimmune diabetes in animal models. Curr Opin Immunol 1998; 10(6):704-709.
(74) Wakeland E, Morel L, Achey K, Yui M, Longmate J. Speed congenics: a classic technique in the fast lane (relatively speaking). Immunol Today 1997; 18:472-477.
(75) Brook FA, Evans EP, Lord CJ, Lyons PA, Rainbow DB, Howlett SK et al. The derivation of highly germline-competent embryonic stem cells containing NOD-derived genome. diab 2003; 52(1):205-208.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12502514
(76) Kawabata Y, Ikegami H, Fujisawa T, Noso S, Asano K, Hiromine Y et al. A second component of HLA-linked susceptibility to type 1 diabetes maps to class I region. Ann N Y Acad Sci 2006; 1079:278-84.:278-284.
(77) Ikegami H, Fujisawa T, Makino S, Ogihara T. Congenic mapping and candidate sequencing of susceptibility genes for Type 1 diabetes in the NOD mouse. Ann N Y Acad Sci 2003; 1005:196-204.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14679059
(78) Takaki T, Lieberman SM, Holl TM, Han B, Santamaria P, Serreze DV et al. Requirement for both H-2Db and H-2Kd for the induction of diabetes by the promiscuous CD8+ T cell clonotype AI4. J Immunol 2004; 173(4):2530-2541.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15294969
(79) Acha-Orbea H, McDevitt HO. The first external domain of the nonobese diabetic mouse class II I-A chain is unique. Proc Natl Acad Sci USA 1987; 84(8):2435-2439.
(80) Nepom GT, Erlich H. MHC class-II molecules and autoimmunity. Ann Rev Immunol 1991; 9:493-525.
(81) Miyazaki T, Uno M, Uehira M, Kikutani H, Kishimoto T, Kimoto M et al. Direct evidence for the contribution of the unique I-ANOD to the development of insulitis in non-obese diabetic mice. Nature 1990; 345(6277):722-724.
(82) Nishimoto H, Kikutani H, Yamamura K, Kishimoto T. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice. Nature 1987; 328(6129):432-434.
(83) Wherrett DK, Singer SM, McDevitt HO. Reduction in diabetes incidence in an I-Ag7 transgenic nonobese diabetic mouse line. diab 1997; 46(12):1970-1974.
(84) Ikegami H, Makino S, Harada M, Eisenbarth GS, Hattori M. The cataract Shionogi mouse,a sister non-obese diabetic mouse similar class II but different class I gene products. diabetol 1988; 31(4):254-258.
(85) Ikegami H, Eisenbarth GS, Hattori M. Major histocompatibility complex-linked diabetogenic gene of the nonobese diabetic mouse. Analysis of genomic DNA amplified by polymerase chain reaction. J Clin Invest 1990; 85(1):18-24.
(86) Wicker LS, Miller BJ, Fischer PA, Pressey A, Peterson LB. Genetic control of diabetes and insulitis in the nonobese diabetic mouse. Pedigree analysis of a diabetic H-2nod/b heterozygote. J Immunol 1989; 142(3):781-784.
PM:2643662
(87) Corper AL, Stratmann T, Apostolopoulos V, Scott CA, Garcia KC, Kang AS et al. A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. Science 2000; 288(5465):505-511.
(88) Latek RR, Suri A, Petzold SJ, Nelson CA, Kanagawa O, Unanue ER et al. Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice. Immunity 2000; 12(6):699-710.
http://www.ncbi.nlm.nih.gov/pubmed/10894169?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(89) Carrasco-Marin E, Kanagawa O, Unanue ER. Insights into the chemistry and biology of the I-Ag7 class II molecule. Res Immunol 1997; 148:291-301.
(90) Kanagawa O, Martin SM, Vaupel BA, Carrasco-Marin E, Unanue ER. Autoreactivity of T cells from nonobese diabetic mice: an I-Ag7-dependent reaction. Proc Natl Acad Sci U S A 1998; 95(4):1721-1724.
PM:9465083
(91) Duarte N, Lundholm M, Holmberg D. The Idd6.2 diabetes susceptibility region controls defective expression of the Lrmp gene in nonobese diabetic (NOD) mice. Immunogenetics 2007; 59(5):407-416.
(92) Schmidt D, Verdaguer J, Averill N, Santamaria P. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity. J Exp Med 1997; 186:1059-1075.
(93) Ridgway WM, Ito H, Fasso M, Yu C, Fathman CG. Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response. J Exp Med 1998; 188(12):2267-2275.
(94) van Rijn JC, Grote FK, Oostdijk W, Wit JM. Short stature and the probability of coeliac disease, in the absence of gastrointestinal symptoms. Arch Dis Child 2004; 89(9):882-883.
(95) Kanagawa O, Vaupel BA, Xu G, Unanue ER, Katz JD. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant. J Immunol 1998; 161(9):4489-4492.
PM:9794372
(96) Suri A, Katz JD. Dissecting the role of CD4+ T cells in autoimmune diabetes through the use of TCR transgenic mice. Immunol Rev 1999; 169:55-65.
(97) Nakayama M, Beilke JN, Jasinski JM, Kobayashi M, Miao D, Li M et al. Priming and effector dependence on insulin B:9-23 peptide in NOD islet autoimmunity. J Clin Invest 2007; 117(7):1835-1843.
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17607359&ordinalpos=20&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum           (98) Thebault-Baumont K, Dubois-LaForgue D, Krief P, Briand JP, Halbout P, Vallon-Geoffroy K et al. Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice. J Clin Invest 2003; 111(6):851-857.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12639991
(99) Levisetti MG, Suri A, Petzold SJ, Unanue ER. The insulin-specific T cells of nonobese diabetic mice recognize a weak MHC-binding segment in more than one form. J Immunol 2007; 178(10):6051-6057.
(100) Ikegami H, Jackson RA, Makino S, Watt DE, Eisenbarth GS, Hattori M. Homozygosity for two genes (H-2: chromosome 17 and Thy-1: chromosome 9) linked to development of type I diabetes of the NOD mouse. Clin Res 34, 683A. 1986.
Ref Type: Abstract
(101) Lyons PA, Hancock WW, Denny P, Lord CJ, Hill NJ, Armitage N et al. The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137. Immunity 2000; 13(1):107-115.
(102) Podolin PL, Wilusz MB, Cubbon RM, Pajvani U, Lord CJ, Todd JA et al. Differential glycosylation of interleukin 2, the molecular basis for the NOD Idd3 type 1 diabetes gene? Cytokine 2000; 12(5):477-482.
(103) Eisenbarth SC, Homann D. "Primer Immunology and Autoimmunity". Type I Diabetes: Molecular, Cellular and Clinical Immunology 2006.
http://barbaradaviscenter.org/
(104) Ikegami H, Fujisawa T, Sakamoto T, Makino S, Ogihara T. Idd1 and Idd3 are necessary but not sufficient for development of type 1 diabetes in NOD mouse. Diabetes Res Clin Pract 2004; 66 Suppl 1:S85-S90.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15563987
(105) del Rio R, Noubade R, Subramanian M, Saligrama N, Diehl S, Rincon M et al. SNPs upstream of the minimal promoter control IL-2 expression and are candidates for the autoimmune disease-susceptibility locus Aod2/Idd3/Eae3. Genes Immun 2008; 9(2):115-121.
http://www.ncbi.nlm.nih.gov/pubmed/18200031?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(106) Ghosh S, Palmer SM, Rodrigues NR, Cordell HJ, Hearne CM, Cornall RJ et al. Polygenic control of autoimmune diabetes in nonobese diabetic mice. Nat Genet 1993; 4:404-409.
(107) McDuffie M, Maybee NA, Keller SR, Stevens BK, Garmey JC, Morris MA et al. Nonobese diabetic (NOD) mice congenic for a targeted deletion of 12/15-lipoxygenase are protected from autoimmune diabetes. Diabetes 2008; 57(1):199-208.
http://www.ncbi.nlm.nih.gov/pubmed/17940120?ordinalpos=121&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(108) Davoodi-Semiromi A, McDuffie M, Litherland S, Clare-Salzler M. Truncated pStat5B is associated with the Idd4 locus in NOD mice. Biochem Biophys Res Commun 2007; 356(3):655-661.
http://www.ncbi.nlm.nih.gov/pubmed/17382905?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(109) Hill NJ, Lyons PA, Armitage N, Todd JA, Wicker LS, Peterson LB. NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans [In Process Citation]. diab 2000; 49(10):1744-1747.
(110) Fox CJ, Paterson AD, Mortin-Toth SM, Danska JS. Two genetic loci regulate T cell-dependent islet inflammation and drive autoimmune diabetes pathogenesis. Am J Hum Genet 2000; 67(1):67-81.
http://www.ncbi.nlm.nih.gov/pubmed/10848492?ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(111) Cordell HJ, Todd JA, Hill NJ, Lord CJ, Lyons PA, Peterson LB et al. Statistical modeling of interlocus interactions in a complex disease: rejection of the multiplicative model of epistasis in type 1 diabetes. Genetics 2001; 158(1):357-367.
PM:11333244
(112) Wicker LS, Chamberlain G, Hunter K, Rainbow D, Howlett S, Tiffen P et al. Fine mapping, gene content, comparative sequencing, and expression analyses support Ctla4 and Nramp1 as candidates for Idd5.1 and Idd5.2 in the nonobese diabetic mouse. J Immunol 2004; 173(1):164-173.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15210771
(113) Greve B, Vijayakrishnan L, Kubal A, Sobel RA, Peterson LB, Wicker LS et al. The diabetes susceptibility locus Idd5.1 on mouse chromosome 1 regulates ICOS expression and modulates murine experimental autoimmune encephalomyelitis. J Immunol 2004; 173(1):157-163.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15210770
(114) Colucci F, Bergman ML, Penha-Goncalves C, Cilio CM, Holmberg D. Apoptosis resistance of nonobese diabetic peripheral lymphocytes linked to the Idd5 diabetes susceptibility region. Proc Natl Acad Sci U S A 1997; 94(16):8670-8674.
PM:9238035
(115) Bergman ML, Cilio CM, Penha-Goncalves C, Lamhamedi-Cherradi SE, Lofgren A, Colucci F et al. CTLA-4-/- mice display T cell-apoptosis resistance resembling that ascribed to autoimmune-prone non-obese diabetic (NOD) mice. J Autoimmun 2001; 16(2):105-113.
PM:11247636
(116) Motta V, Lejon K, Holmberg D. The NOD allele of the Idd5 locus on chromosome 1 mediates a non-cell-autonomous defect in negative selection of T cells. J Autoimmun 2007; 28(4):216-223.
(117) Irie J, Reck B, Wu Y, Wicker LS, Howlett S, Rainbow D et al. Genome-wide microarray expression analysis of CD4+ T Cells from nonobese diabetic congenic mice identifies Cd55 (Daf1) and Acadl as candidate genes for type 1 diabetes. J Immunol 2008; 180(2):1071-1079.
http://www.ncbi.nlm.nih.gov/pubmed/18178847?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(118) Carnaud C, Gombert J, Donnars O, Garchon H, Herbelin A. Protection against diabetes and improved NK/NKT cell performance in NOD.NK1.1 mice congenic at the NK complex. J Immunol 2001; 166(4):2404-2411.
PM:11160299
(119) Laloux V, Beaudoin L, Jeske D, Carnaud C, Lehuen A. NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen. J Immunol 2001; 166(6):3749-3756.
PM:11238616
(120) Sharif S, Arreaza GA, Zucker P, Mi QS, Sondhi J, Naidenko OV et al. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med 2001; 7(9):1057-1062.
http://www.ncbi.nlm.nih.gov/pubmed/11533711?ordinalpos=4&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(121) Bergman ML, Penha-Goncalves C, Lejon K, Holmberg D. Low rate of proliferation in immature thymocytes of the non-obese diabetic mouse maps to the Idd6 diabetes susceptibility region. diabetol 2001; 44(8):1054-1061.
PM:11484085
(122) Vallois D, Grimm CH, Avner P, Boitard C, Rogner UC. The type 1 diabetes locus Idd6 controls TLR1 expression. J Immunol 2007; 179(6):3896-3903.
(123) Serreze DV, Choisy-Rossi CM, Grier AE, Holl TM, Chapman HD, Gahagan JR et al. Through regulation of TCR expression levels, an Idd7 region gene(s) interactively contributes to the impaired thymic deletion of autoreactive diabetogenic CD8+ T cells in nonobese diabetic mice. J Immunol 2008; 180(5):3250-3259.
http://www.ncbi.nlm.nih.gov/pubmed/18292549?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(124) Siegmund T, Armitage N, Wicker LS, Peterson LB, Todd JA, Lyons PA. Analysis of the mouse CD30 gene: a candidate for the NOD mouse type 1 diabetes locus Idd9.2. diab 2000; 49(9):1612-1616.
PM:10969850
(125) Heath VL, Moore NC, Parnell SM, Mason DW. Intrathymic expression of genes involved in organ specific autoimmune disease. J Autoimmun 1998; 11(4):309-318.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=9776708
(126) Yamaji K, Ikegami H, Fujisawa T, Noso S, Nojima K, Babaya N et al. Evidence for Cd101 but not Fcgr1 as candidate for type 1 diabetes locus, Idd10. Biochem Biophys Res Commun 2005; 331(2):536-542.
http://www.ncbi.nlm.nih.gov/pubmed/15850792?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(127) Podolin PL, Denny P, Lord CJ, Hill NJ, Todd JA, Peterson LB et al. Congenic mapping of the insulin-dependent diabetes (Idd) gene, Idd10, localizes two genes mediating the Idd10 effect and eliminates the candidate Fcgr1. J Immunol 1997; 159(4):1835-1843.
(128) Chen YG, Driver JP, Silveira PA, Serreze DV. Subcongenic analysis of genetic basis for impaired development of invariant NKT cells in NOD mice. Immunogenetics 2007; 59(9):705-712.
http://www.ncbi.nlm.nih.gov/pubmed/17619875?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(129) Schmidt MB. Eine biglandulare Erkrankung (Nebennieren und Schilddruse) bei Morbus Addisonii. Verh Dtsch Ges Pathol 1926; 21:212-221.
(130) Liston A, Gray DH, Lesage S, Fletcher AL, Wilson J, Webster KE et al. Gene dosage--limiting role of Aire in thymic expression, clonal deletion, and organ-specific autoimmunity. J Exp Med 2004; 200(8):1015-1026.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15492124
(131) Anderson MS. Autoimmune endocrine disease. Curr Opin Immunol 2002; 14(6):760-764.
PM:12413526
(132) Adams TE, Apert S, Hanahan D. Non-tolerance and autoantibodies to a transgenic self-antigen expressed in pancreatic beta cells. Nature 1987; 325:223-228.
(133) Hanahan D. Peripheral-antigen-expressing cells in thymic medulla: factors in self- tolerance and autoimmunity. Curr Opin Immunol 1998; 10(6):656-662.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=9914224
(134) Pugliese A. Genetics of type 1 diabetes. Endocrinol Metab Clin North Am 2004; 33(1):1-16, vii.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15053891
(135) Cetani F, Barbesino G, Borsari S, Pardi E, Cianferotti L, Pinchera A et al. A novel mutation of the autoimmune regulator gene in an Italian kindred with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, acting in a dominant fashion and strongly cosegregating with hypothyroid autoimmune thyroiditis. J Clin Endocrinol Metab 2001; 86(10):4747-4752.
http://www.ncbi.nlm.nih.gov/pubmed/11600535?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(136) Gray DH, Gavanescu I, Benoist C, Mathis D. Danger-free autoimmune disease in Aire-deficient mice. Proc Natl Acad Sci U S A 2007; 104(46):18193-18198.
http://www.ncbi.nlm.nih.gov/pubmed/17991771?ordinalpos=102&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(137) Gambineri E, Torgerson TR, Ochs HD. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Current Opinion in Rheumatology 2003; 15(4):430-435.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12819471
(138) Patel DD. Escape from tolerance in the human X-linked autoimmunity-allergic disregulation syndrome and the Scurfy mouse. J Clin Invest 2001; 107(2):155-157.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11160129&query_hl=7
(139) Chen Z, Benoist C, Mathis D. How defects in central tolerance impinge on a deficiency in regulatory T cells. Proc Natl Acad Sci U S A 2005; 102(41):14735-14740.
(140) Griffiths MM, Encinas JA, Remmers EF, Kuchroo VK, Wilder RL. Mapping autoimmunity genes. Curr Opin Immunol 1999; 11(6):689-700.
PM:10631556
(141) Fairhurst AM, Wandstrat AE, Wakeland EK. Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease. Adv Immunol 2006; 92:1-69.:1-69.
http://www.ncbi.nlm.nih.gov/pubmed/17145301?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(142) Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004; 36(4):337-338.
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15004560
(143) Smyth D, Cooper JD, Collins JE, Heward JM, Franklyn JA, Howson JM et al. Replication of an Association Between the Lymphoid Tyrosine Phosphatase Locus (LYP/PTPN22) With Type 1 Diabetes, and Evidence for Its Role as a General Autoimmunity Locus. diab 2004; 53(11):3020-3023.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15504986
(144) Velaga MR, Wilson V, Jennings CE, Owen CJ, Herington S, Donaldson PT et al. The Codon 620 Tryptophan Allele of the Lymphoid Tyrosine Phosphatase (LYP) Gene Is a Major Determinant of Graves' Disease. J Clin Endocrinol Metab 2004; 89(11):5862-5865.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15531553
(145) Salomon B, Rhee L, Bour-Jordan H, Hsin H, Montag A, Soliven B et al. Development of spontaneous autoimmune peripheral polyneuropathy in b7-2-deficient nod mice. J Exp Med 2001; 194(5):677-684.
http://www.ncbi.nlm.nih.gov/pubmed/11535635?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(146) Winer S, Tsui H, Lau A, Song A, Li X, Cheung RK et al. Autoimmune islet destruction in spontaneous type 1 diabetes is not beta-cell exclusive. Nat Med 2003; 9(2):198-205.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12539039
(147) Winer S, Astsaturov I, Cheung R, Gunaratnam L, Kubiak V, Cortez MA et al. Type I diabetes and multiple sclerosis patients target islet plus central nervous system autoantigens; nonimmunized nonobese diabetic mice can develop autoimmune encephalitis. J Immunol 2001; 166(4):2831-2841.
PM:11160351
(148) Rivero VE, Cailleau C, Depiante-Depaoli M, Riera CM, Carnaud C. Non-obese diabetic (NOD) mice are genetically susceptible to experimental autoimmune prostatitis (EAP). J Autoimmun 1998; 11(6):603-610.
PM:9878082
(149) Koarada S, Wu Y, Fertig N, Sass DA, Nalesnik M, Todd JA et al. Genetic control of autoimmunity: protection from diabetes, but spontaneous autoimmune biliary disease in a nonobese diabetic congenic strain. J Immunol 2004; 173(4):2315-2323.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15294944
(150) Bendelac A, Carnaud C, Boitard C, Bach JF. Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates.  Requirement for both L3T4+ and Lyt-2+ T cells. J Exp Med 1987; 166:823-32.
(151) Wicker LS, Miller BJ, Mullen Y. Transfer of autoimmune diabetes mellitus with splenocytes from non-obese diabetic (NOD) mice. diab 1986; 35(8):855-60.
(152) Charlton B, Mandel TE. Progression from insulitis to Beta cell destruction in NOD mouse requires L3T4+T-lymphocytes. diab 1988; 37:1108-12.
(153) Serreze DV, Chapman HD, Varnum DS, Hanson MS, Reifsnyder PC, Scott DR et al. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed-congenic" stock of NOD.Igunull mice. J Exp Med 1996; 184:2049-2053.
(154) Greeley SA, Katsumata M, Yu L, Eisenbarth GS, Moore DJ, Goodarzi H et al. Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat Med 2002; 8(4):399-402.
http://www.ncbi.nlm.nih.gov/pubmed/11927947?ordinalpos=4&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(155) Sreenan S, Pick AJ, Levisetti M, Baldwin AC, Pugh W, Polonsky KS. Increased b-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse. diab 1999; 48:989-996.
(156) Valorani MG, Hawa MI, Buckley LR, Afeltra A, Cacciapaglia F, Pozzilli P. The natural history of insulin content in the pancreas of female and male non-obese diabetic mouse: implications for trials of diabetes prevention in humans. Diabetes Metab Res Rev 2004; 20(5):394-398.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15343585
(157) Nir T, Melton DA, Dor Y. Recovery from diabetes in mice by beta cell regeneration. J Clin Invest 2007; 117(9):2553-2561.
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17786244
(158) Meier JJ, Lin JC, Butler AE, Galasso R, Martinez DS, Butler PC. Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes. Diabetologia 2006; 49(8):1838-1844.
(159) Butler AE, Galasso R, Meier JJ, Basu R, Rizza RA, Butler PC. Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis. diabetol 2007; 50(11):2323-2331.
http://www.ncbi.nlm.nih.gov/pubmed/17805509?dopt=Citation
(160) Keenan HA, Costacou T, Sun JK, Doria A, Cavellerano J, Coney J et al. Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration: the 50-year medalist study. Diabetes Care 2007; 30(8):1995-1997.
(161) Sherry NA, Kushner JA, Glandt M, Kitamura T, Brillantes AM, Herold KC. Effects of autoimmunity and immune therapy on beta-cell turnover in type 1 diabetes. Diabetes 2006; 55(12):3238-3245.
(162) Haskins K, Atkinson M. Prediction of Diabetes and Response to Therapy in Individual Animals: are there Lessons for Man? Report on the JDF/Snow Mountain Meeting, 5-7 October 2000, Winter Park, CO, USA. J Autoimmun 2001; 16(1):15-19.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11221992
(163) Bonifacio E, Atkinson M, Eisenbarth G, Serreze D, Kay TW, Lee-Chan E et al. International Workshop on Lessons from Animal Models for Human Type 1 Diabetes: analyzing target autoantigens of humoral immunity in nonobese diabetic mice. Ann N Y Acad Sci 2002; 958:1-2.
http://www.ncbi.nlm.nih.gov/pubmed/12021078?ordinalpos=4&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(164) Yu L, Eisenbarth GS, Bonifacio E, Thomas J, Atkinson M, Wasserfall C. The Second Murine Autoantibody Workshop: remarkable inter-laboratory concordance for radiobinding assays to identify insulin autoantibodies in non-obese diabetic mice. NY Acad Sci 2003; 100:1-12.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14679035
(165) Moore DJ, Noorchashm H, Lin TH, Greeley SA, Naji A. NOD B-cells are insufficient to incite T-cell-mediated anti-islet autoimmunity. Diabetes 2005; 54(7):2019-2025.
http://www.ncbi.nlm.nih.gov/pubmed/15983202?ordinalpos=12&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(166) Noorchashm H, Noorchashm N, Kern J, Rostami SY, Barker CF, Naji A. B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. diab 1997; 46(6):941-946.
(167) Kendall PL, Yu G, Woodward EJ, Thomas JW. Tertiary lymphoid structures in the pancreas promote selection of B lymphocytes in autoimmune diabetes. J Immunol 2007; 178(9):5643-5651.
(168) Hu CY, Rodriguez-Pinto D, Du W, Ahuja A, Henegariu O, Wong FS et al. Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J Clin Invest 2007; 117(12):3857-3867.
PM:18060033
(169) Hoglund P, Mintern J, Waltzinger C, Heath W, Benoist C, Mathis D. Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J Exp Med 1999; 189(2):331-339.
(170) Denis MC, Mahmood U, Benoist C, Mathis D, Weissleder R. Imaging inflammation of the pancreatic islets in type 1 diabetes. Proc Natl Acad Sci U S A 2004; 101(34):12634-12639.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15304647
(171) Lejon K, Fathman CG. Isolation of self antigen-reactive cells from inflamed islets of nonobese diabetic mice using CD4high expression as a marker. J Immunol 1999; 163(10):5708-5714.
PM:10553102
(172) Gagnerault MC, Luan JJ, Lotton C, Lepault F. Pancreatic lymph nodes are required for priming of beta cell reactive T cells in NOD mice. J Exp Med 2002; 196(3):369-377.
PM:12163565
(173) Poirot L, Benoist C, Mathis D. Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity. Proc Natl Acad Sci U S A 2004; 101(21):8102-8107.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15141080
(174) Serreze DV, Gaskins HR, Leiter EH. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. J Immunol 1993; 150(6):2534-2543.
PM:8450229
(175) Piganelli JD, Martin T, Haskins K. Splenic macrophages from the NOD mouse are defective in the ability to present antigen. diab 1998; 47:1212-1218.
(176) Dahlen E, Hedlund G, Dawe K. Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation. J Immunol 2000; 164(5):2444-2456.
(177) Strid J, Lopes L, Marcinkiewicz J, Petrovska L, Nowak B, Chain BM et al. A defect in bone marrow derived dendritic cell maturation in the nonobesediabetic mouse. Clin Exp Immunol 2001; 123(3):375-381.
PM:11298122
(178) Wong FS, Karttunen J, Dumont C, Wen L, Visintin I, Pilip IM et al. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nat Med 1999; 5(9):1026-1031.
(179) Buchs AE, Rapoport MJ. T cell signaling and autoimmune diabetes. J Pediatr Endocrinol Metab 2000; 13(9):1549-1554.
PM:11154149
(180) Zhang J, Salojin KV, Delovitch TL. CD28 co-stimulation restores T cell responsiveness in NOD mice by overcoming deficiencies in Rac-1/p38 mitogen-activated protein kinase signaling and IL-2 and IL-4 gene transcription. Int Immunol 2001; 13(3):377-384.
PM:11222507
(181) King C, Ilic A, Koelsch K, Sarvetnick N. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 2004; 117(2):265-277.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15084263
(182) Lang J, Bellgrau D. A T-cell functional phenotype common among autoimmune-prone rodent strains. Scand J Immunol 2002; 55(6):546-559.
PM:12028557
(183) McInerney MF, Pek SB, Thomas DW. Prevention of insulitis and diabetes onset by treatment with complete Freund's adjuvant in NOD mice. diab 1991; 40(6):715-725.
(184) Guytingco R, Quddus J, Richardson B, Pek SB. Single administration of bacillus Calmette-Guerin (BCG) vaccine in nonobese diabetic (NOD) mice results in suppression of in vitro T-lymphocyte proliferation and regression of insulitis. Diabetes 40, 152A. 1991.
Ref Type: Abstract
(185) Singh B. Stimulation of the developing immune system can prevent autoimmunity. J Autoimmun 2000; 14(1):15-22.
PM:10648113
(186) Ridgway WM, Fassò M, Lanctot A, Garvey C, Fathman CG. Breaking self-tolerance in nonobese diabetic mice. J Exp Med 1996; 183:1657-1662.
(187) Boyton RJ, Lohmann T, Londei M, Kalbacher H, Halder T, Frater AJ et al. Glutamic acid decarboxylase T lymphocyte responses associated with susceptibility or resistance to type I diabetes: analysis in disease discordant human twins, non-obese diabetic mice and HLA-DQ transgenic mice. Int Immunol 1998; 10(12):1765-1776.
(188) Dosch HM, Becker DJ. Measurement of T-cell autoreactivity in autoimmune diabetes [letter] [In Process Citation]. diabetol 2000; 43(3):386-387.
(189) Kreuwel HT, Biggs JA, Pilip IM, Pamer EG, Lo D, Sherman LA. Defective CD8+ T cell peripheral tolerance in nonobese diabetic mice. J Immunol 2001; 167(2):1112-1117.
PM:11441123
(190) Tian J, Gregori S, Adorini L, Kaufman DL. The frequency of high avidity T cells determines the hierarchy of determinant spreading. J Immunol 2001; 166(12):7144-7150.
PM:11390460
(191) Hutton JC, Eisenbarth GS. A pancreatic {beta}-cell-specific homolog of glucose-6-phosphatase emerges as a major target of cell-mediated autoimmunity in diabetes. Proc Natl Acad Sci U S A 2003; 100:8626-8628.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=12861077
(192) Trudeau JD, Kelly-Smith C, Verchere CB, Elliott JF, Dutz JP, Finegood DT et al. Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J Clin Invest 2003; 111(2):217-223.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12531877
(193) Amrani A, Verdaguer J, Serra P, Tafuro S, Tan R, Santamaria P. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature 2000; 406(6797):739-742.
http://www.ncbi.nlm.nih.gov/pubmed/10963600?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(194) Naquet P, Naspetti M, Boyd R. Development, organization and function of the thymic medulla in normal, immunodeficient or autoimmune mice. Semin Immunol 1999; 11(1):47-55.
PM:9950751
(195) Lord CJ, Howlett S, Lyons PA, Peterson LB, Wicker LS, Todd JA. The murine type 1 diabetes loci, Idd1, Idd3, Idd5, Idd9, and Idd17/10/18, do not control thymic CD4-CD8-/TCRalphabeta+ deficiency in the nonobese diabetic mouse. Mamm Genome 2001; 12(2):175-176.
PM:11210190
(196) Bluestone JA, Tang Q. Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells. Proc Natl Acad Sci U S A 2004; 101 Suppl 2:14622-14626.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15322272
(197) Tang Q, Bluestone JA. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol 2008; 9(3):239-244.
(198) Masteller EL, Warner MR, Tang Q, Tarbell KV, McDevitt H, Bluestone JA. Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice. J Immunol 2005; 175(5):3053-3059.
(199) Hutchings PR, Cooke A. The transfer of autoimmune diabetes in NOD mice can be inhibited or accelerated by distinct cell populations present in normal splenocytes taken from young males. J Autoimmun 1990; 3(2):175-185.
PM:1971173
(200) Boitard C, Yasunami R, Dardenne M, Bach JF. T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J Exp Med 1989; 169(5):1669-1680.
PM:2523954
(201) Belghith M, Bluestone JA, Barriot S, Megret J, Bach JF, Chatenoud L. TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat Med 2003; 9(9):1202-1208.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12937416
(202) Weiner HL. Oral tolerance, an active immunologic process mediated by multiple mechanisms. J Clin Invest 2000; 106(8):935-937.
PM:11032852
(203) Roncarolo MG, Gregori S. Is FOXP3 a bona fide marker for human regulatory T cells? Eur J Immunol 2008; 38(4):925-927.
http://www.ncbi.nlm.nih.gov/pubmed/18395862?ordinalpos=8&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(204) Trucco M, Giannoukakis N. Immunoregulatory dendritic cells to prevent and reverse new-onset Type 1 diabetes mellitus. Expert Opin Biol Ther 2007; 7(7):951-963.
(205) Du W, Wong FS, Li MO, Peng J, Qi H, Flavell RA et al. TGF-beta signaling is required for the function of insulin-reactive T regulatory cells. J Clin Invest 2006; 116(5):1360-1370.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=16670772
(206) Pop SM, Wong CP, He Q, Wang Y, Wallet MA, Goudy KS et al. The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice. Diabetes 2007; 56(5):1395-1402.
(207) Fehervari Z, Sakaguchi S. CD4(+) Tregs and immune control. J Clin Invest 2004; 114(9):1209-1217.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15520849
(208) Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299(5609):1057-1061.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12522256
(209) Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003; 4(4):330-336.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12612578
(210) Jaeckel E, von Boehmer H, Manns MP. Antigen-Specific FoxP3-Transduced T-Cells Can Control Established Type 1 Diabetes. diab 2005; 54(2):306-310.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15591438
(211) Mchugh RS, Shevach EM. Cutting edge: Depletion of CD4(+)CD25(+) regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. Journal of Immunology 2002; 168(12):5979-5983.
ISI:000176145300001
(212) Peng Y, Laouar Y, Li MO, Green EA, Flavell RA. TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes. Proc Natl Acad Sci U S A 2004; 101(13):4572-4577.
PM:15070759
(213) Tang Q, Henriksen KJ, Bi M, Finger EB, Szot G, Ye J et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 2004; 199(11):1455-1465.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15184499
(214) Lenschow DJ, Herold KC, Rhee L, Patel B, Koons A, Qin HY et al. CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes [published erratum appears in Immunity 1997 Feb;6(2):following 215]. Immunity 1996; 5(3):285-293.
(215) Herman AE, Freeman GJ, Mathis D, Benoist C. CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J Exp Med 2004; 199(11):1479-1489.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15184501
(216) Mukherjee R, Chaturvedi P, Qin HY, Singh B. CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells. J Autoimmun 2003; 21(3):221-237.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14599847
(217) Harrison LC, Solly NR, Martinez NR. (Pro)insulin-specific regulatory T cells. Novartis Found Symp 2003; 252:132-141.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14609216
(218) Gombert JM, Herbelin A, Tancrede-Bohin E, Dy M, Carnaud C, Bach JF. Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse. Eur J Immunol 1996; 26(12):2989-2998.
(219) Falcone M, Yeung B, Tucker L, Rodriguez E, Sarvetnick N. A defect in interleukin 12-induced activation and interferon gamma secretion of peripheral natural killer T cells in nonobese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus. J Exp Med 1999; 190(7):963-972.
(220) Lee IF, Qin H, Trudeau J, Dutz J, Tan R. Regulation of autoimmune diabetes by complete Freund's adjuvant is mediated by NK cells. J Immunol 2004; 172(2):937-942.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14707066
(221) Homann D, Jahreis A, Wolfe T, Hughes A, Coon B, van Stipdonk MJ et al. CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells. Immunity 2002; 16(3):403-415.
PM:11911825
(222) Wegmann DR, Norbury-Glaser M, Daniel D. Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice. Eur J Immunol 1994; 24(8):1853-1857.
(223) Lieberman SM, Evans AM, Han B, Takaki T, Vinnitskaya Y, Caldwell JA et al. Identification of the {beta} cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes. Proc Natl Acad Sci U S A 2003; 100(14):8384-8388.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12815107
(224) Lieberman SM, DiLorenzo TP. A comprehensive guide to antibody and T-cell responses in type 1 diabetes. Tissue Antigens 2003; 62(5):359-377.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14617043
(225) Jaeckel E, Klein L, Martin-Orozco N, von Boehmer H. Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylase. J Exp Med 2003; 197(12):1635-1644.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12796471
(226) Lieberman SM, Takaki T, Han B, Santamaria P, Serreze DV, DiLorenzo TP. Individual nonobese diabetic mice exhibit unique patterns of CD8+ T cell reactivity to three islet antigens, including the newly identified widely expressed dystrophia myotonica kinase. J Immunol 2004; 173(11):6727-6734.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15557165
(227) Cohen IR. Thoughts on the pathogenesis of type 1 diabetes and on the arrest of autoimmune beta-cell destruction by peptide p277 vaccination. Isr Med Assoc J 2004; 6(5):260-261.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15151361
(228) Bonifacio E, Atkinson M, Eisenbarth GS, Serreze D, Kay TW, Lee-Chan E et al. International workshop on autoimmunity in animal models of autoimmune diabetes identifies insulin, but not GAD or IA-2 as specific antigens of humoral autoimmunity in the non-obese diabetic mouse. diab 2001; 50:2451-2458.
(229) Daniel D, Gill RG, Schloot N, Wegmann D. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur J Immunol 1995; 25(4):1056-1062.
(230) Jaeckel E, Lipes MA, von Boehmer H. Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes. Nat Immunol 2004; 5(10):1028-1035.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15378058
(231) Narendran P, Mannering SI, Harrison LC. Proinsulin - a pathogenic autoantigen in type 1 diabetes. Autoimmunity Reviews 2003; 2(4):204-210.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12848947
(232) Muir A, Luchetta R, Song H-Y, Peck A, Krischer J, Maclaren N. Insulin immunization protects NOD mice from diabetes. Autoimmunity 15, 58. 1993.
Ref Type: Abstract
(233) Muir A, Peck A, Clare-Salzler M, Song Y-H, Cornelius J, Luchetta R et al. Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription. J Clin Invest 1995; 95(2):628-634.
(234) Hancock WW, Polansky M, Zhang J, Blogg N, Weiner HL. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E. Am J Pathol 1995; 147(5):1193-1199.
(235) Zhang ZJ, Davidson L, Eisenbarth G, Weiner HL. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci U S A 1991; 88(22):10252-10256.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=1946445
(236) Simone E, Daniel D, Schloot N, Gottlieb P, Babu S, Kawasaki E et al. T cell receptor restriction of diabetogenic autoimmune NOD T cells. Proc Natl Acad Sci USA 1997; 94(6):2518-2521.
(237) Simone EA, Yu L, Wegmann DR, Eisenbarth GS. T cell receptor gene polymorphisms associated with anti-insulin, autoimmune T cells in diabetes-prone NOD mice. J Autoimmun 1997; 10:317-321.
(238) Abiru N, Wegmann D, Kawasaki E, Gottlieb P, Simone E, Eisenbarth GS. Dual overlapping peptides recognized by insulin peptide B:9-23 reactive T cell receptor AV13S3 T cell clones of the NOD mouse. J Autoimmun 2000; 14(3):231-237.
(239) Daniel D, Wegmann DR. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc Natl Acad Sci USA 1996; 93(2):956-960.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=8570667&query_hl=58&itool=pubmed_docsum
(240) Wong FS, Janeway CAJ. The role of CD4 vs. CD8 T cells in IDDM. J Autoimmun 1999; 13(3):290-295.
(241) Faideau B, Briand JP, Lotton C, Tardivel I, Halbout P, Jami J et al. Expression of preproinsulin-2 gene shapes the immune response to preproinsulin in normal mice. J Immunol 2004; 172(1):25-33.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14688305
(242) Devendra D, Paronen J, Moriyama H, Miao D, Eisenbarth GS, Liu E. Differential immune response to B:9-23 insulin 1 and insulin 2 peptides in animal models of type 1 diabetes. Journal of Autoimmunity 2004; 23(1):17-26.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15236749
(243) French MB, Allison J, Cram DS, Thomas HE, Dempsey-Collier M, Silva A et al. Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. diab 1996; 46:34-39.
(244) Steptoe RJ, Ritchie JM, Harrison LC. Transfer of hematopoietic stem cells encoding autoantigen prevents autoimmune diabetes. J Clin Invest 2003; 111(9):1357-1363.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12727927
(245) DiLorenzo TP, Serreze DV. The good turned ugly: immunopathogenic basis for diabetogenic CD8+ T cells in NOD mice. Immunol Rev 2005; 204:250-63.:250-263.
(246) Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A 2007; 104(43):17040-17045.
http://www.ncbi.nlm.nih.gov/pubmed/17942684?ordinalpos=8&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(247) Krishnamurthy B, Dudek NL, McKenzie MD, Purcell AW, Brooks AG, Gellert S et al. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP. J Clin Invest 2006; 116(12):3258-3265.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17143333&query_hl=7&itool=pubmed_docsum
(248) Levisetti MG, Suri A, Petzold SJ, Unanue ER. The insulin-specific T cells of nonobese diabetic mice recognize a weak MHC-binding segment in more than one form. J Immunol 2007; 178(10):6051-6057.
(249) Bresson D, von Herrath M. Moving towards efficient therapies in type 1 diabetes: to combine or not to combine? Autoimmun Rev 2007; 6(5):315-322.
(250) Fukushima K, Abiru N, Nagayama Y, Kobayashi M, Satoh T, Nakahara M et al. Combined insulin B:9-23 self-peptide and polyinosinic-polycytidylic acid accelerate insulitis but inhibit development of diabetes by increasing the proportion of CD4+Foxp3+ regulatory T cells in the islets in non-obese diabetic mice. Biochem Biophys Res Commun 2008; 367(4):719-724.
http://www.ncbi.nlm.nih.gov/pubmed/18194666?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(251) Pugliese A, Zeller M, Fernandez A, Zalcberg LJ, Bartlett RJ, Ricordi C et al. The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type I diabetes. Nat Genet 1997; 15(3):293-297.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=9054945
(252) Pugliese A, Brown D, Garza D, Zeller M, Redondo MJ, Eisenbarth GS et al. Self-Antigen Presenting Cells Expressing Islet Cell Molecules in Human Thymus and Peripheral Lymphoid Organs: Phenotypic Characterization and Implications for Immunological Tolerance and Type 1 Diabetes. J Clin Invest 2001; 107(5):555-564.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11238556
(253) Kash SF, Condie BG, Baekkeskov S. Glutamate decarboxylase and GABA in pancreatic islets: lessons from knock-out mice. Horm Metab Res 1999; 31(5):340-344.
(254) Kubosaki A, Gross S, Miura J, Saeki K, Zhu M, Nakamura S et al. Targeted disruption of the IA-2beta gene causes glucose intolerance and impairs insulin secretion but does not prevent the development of diabetes in NOD mice. diab 2004; 53(7):1684-1691.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15220191
(255) Kubosaki A, Miura J, Notkins AL. IA-2 is not required for the development of diabetes in NOD mice. diabetol 2004; 47(1):149-150.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14614561
(256) Kim SK, Tarbell KV, Sanna M, Vadeboncoeur M, Warganich T, Lee M et al. Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells. Proc Natl Acad Sci U S A 2004; 101(39):14204-14209.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15381770
(257) Burton AR, Vincent E, Arnold PY, Lennon GP, Smeltzer M, Li CS et al. On the pathogenicity of autoantigen-specific T-cell receptors. Diabetes 2008; 57(5):1321-1330.
http://www.ncbi.nlm.nih.gov/pubmed/18299317?ordinalpos=7&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(258) Kim SK, Tarbell KV, Sanna M, Vadeboncoeur M, Warganich T, Lee M et al. Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells. Proc Natl Acad Sci U S A 2004; 101(39):14204-14209.
http://www.ncbi.nlm.nih.gov/pubmed/15381770?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(259) Yoon JW, Yoon CS, Lim HW, Huang QQ, Kang Y, Pyun KH et al. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells. Science 1999; 284(5417):1183-1187.
(260) Quintana FJ, Carmi P, Cohen IR. DNA vaccination with heat shock protein 60 inhibits cyclophosphamide-accelerated diabetes. J Immunol 2002; 169(10):6030-6035.
PM:12421990
(261) Ablamunits V, Elias D, Reshef T, Cohen IR. Islet T cells secreting IFN-gamma in NOD mouse diabetes: arrest by p277 peptide treatment. J Autoimmun 1998; 11(1):73-81.
(262) Elias D, Meilin A, Ablamunits V, Birk OS, Carmi P, Könen-Waisman S et al. Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various b-cell antigens. diab 1997; 46:758-764.
(263) Knip M, Karjalainen J, Akerblom HK. Islet cell antibodies are less predictive of IDDM among unaffected children in the general population than in sibs of children with diabetes. The Childhood Diabetes in Finland Study Group. Diab care 1998; 21(10):1670-1673.
(264) Bowman M, Atkinson MA. Heat shock protein therapy fails to prevent diabetes in NOD mice. diabetol 2002; 45(9):1350-1351.
PM:12242470
(265) Nakhooda AF, Like AA, Chappel CI, Murray FT, Marliss EB. The spontaneously diabetic Wistar rat: metabolic and morphologic studies. diab 2001; 26:100-112.
(266) Like AA, Rossini AA. Spontaneous autoimmune diabetes mellitus in the BioBreeding/Worcester rat. Surv Synth Path Res 1984; 3(2):131-138.
(267) Colle E, Guttmann RD, Seemayer T. Spontaneous diabetes mellitus syndrome in the rat. I. Association with the major histocompatibility complex. J Exp Med 1981; 154(4):1237-1242.
(268) Guttmann RD, Colle E, Michel F, Seemayer T. Spontaneous diabetes mellitus syndrome in the rat.  II. T lymphopenia and its association with clinical disease and pancreatic lymphocytic infiltration. J Immunol 1983; 130(4):1732-1735.
(269) Elder ME, Maclaren NK. Identification of profound peripheral T lymphocyte immunodeficiencies in the spontaneously diabetic BB rat. J Immunol 1983; 130(4):1723-1731.
PM:6220066
(270) Bellgrau D, Naji A, Silvers WK, Markmann JF, Barker CF. Spontaneous diabetes in BB rats: evidence for T cell dependent immune response defect. diabetol 1982; 23(4):359-364.
(271) Woda BA, Like AA, Padden C, McFadden ML. Deficiency of phenotypic cytotoxic-suppressor T lymphocytes in the BB/W rat. J Immunol 1986; 136(3):856-859.
PM:2934480
(272) Sellins KS, Gold DP, Bellgrau D. Resistance to tolerance induction in the diabetes-prone biobreeding rat as one manifestation of abnormal responses to superantigens. diabetol 1996; 39(1):28-36.
(273) Crisa L, Mordes JP, Rossini AA. Autoimmune diabetes mellitus in the BB rat. Diabetes Metab Rev 1992; 8(1):4-37.
(274) Mordes JP, Bortell R, Doukas J, Rigby M, Whalen B, Zipris D et al. The BB/Wor rat and the balance hypothesis of autoimmunity. Diabetes Metab Rev 1996; 12(2):103-109.
(275) Prins JB, Herberg L, den Bieman M, van Zutpen B. Genetic variation within and between lines of diabetes-prone and non-diabetes-prone BB rats: allele distribution of 8 protein markers. Lab Anim 2001; 25:207-211.
(276) Butler L, Guberski DL, Like A. Changes in penetrance and onset of sontaneous diabetes in the BB/Wor rat. In: Shafrir E, editor. Frontier in Diabetes Research II. Lessons from Animal Diabetes III. 1990: 50-53.
(277) Zipris D, Lien E, Nair A, Xie JX, Greiner DL, Mordes JP et al. TLR9-signaling pathways are involved in Kilham rat virus-induced autoimmune diabetes in the biobreeding diabetes-resistant rat. J Immunol 2007; 178(2):693-701.
http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&db=PubMed&cmd=Search&term=178%5Bvolume%5D%20AND%20693%5Bpage%5D%20AND%202007%5Bpdat%5D
(278) Colle E, Fuks A, Poussier P, Edouard P, Guttman RD. Polygenic nature of spontaneous diabetes in the rat:  Permisive MHC haplotype and presence of the lymphopenic trait of the BB rat are not sufficient to produce susceptibility. diab 1992; 41:1617-1623.
(279) Jackson RA, Buse JB, Rifai R, Pelletier D, Milford EL, Carpenter CB et al. Two genes required for diabetes in BB rats. Evidence from cyclical intercrosses and backcrosses. J Exp Med 1984; 159(6):1629-1636.
(280) Pandarpurkar M, Wilson-Fritch L, Corvera S, Markholst H, Hornum L, Greiner DL et al. Ian4 is required for mitochondrial integrity and T cell survival. Proc Natl Acad Sci U S A 2003; 100(18):10382-10387.
http://www.ncbi.nlm.nih.gov/pubmed/12930893?ordinalpos=6&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(281) Lang JA, Kominski D, Bellgrau D, Scheinman RI. Partial activation precedes apoptotic death in T cells harboring an IAN gene mutation. Eur J Immunol 2004; 34(9):2396-2406.
http://www.ncbi.nlm.nih.gov/pubmed/15307172?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(282) Nitta T, Nasreen M, Seike T, Goji A, Ohigashi I, Miyazaki T et al. IAN family critically regulates survival and development of T lymphocytes. PLoS Biol 2006; 4(4):e103.
http://www.ncbi.nlm.nih.gov/pubmed/16509771?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(283) Ellerman KE, Like AA. Susceptibility to diabetes is widely distributed in normal class IIu haplotype rats. diabetol 2000; 43(7):890-898.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=10952462&query_hl=25&itool=pubmed_docsum
(284) Martin AM, Maxson MN, Leif J, Mordes JP, Greiner DL, Blankenhorn EP. Diabetes-prone and diabetes-resistant BB rats share a common major diabetes susceptibility locus, iddm4: additional evidence for a "universal autoimmunity locus" on rat chromosome 4. diab 1999; 48(11):2138-2144.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10535446
(285) Kloting I, I, van den BJ, Kovacs P. Quantitative trait loci for blood glucose confirm diabetes predisposing and protective genes, Iddm4 and Iddm5r, in the spontaneously diabetic BB/OK rat. Int J Mol Med 1998; 2(5):597-601.
PM:9858659
(286) Wallis RH, Wang K, Dabrowski D, Marandi L, Ning T, Hsieh E et al. A novel susceptibility locus on rat chromosome 8 affects spontaneous but not experimentally induced type 1 diabetes. Diabetes 2007; 56(6):1731-1736.
http://www.ncbi.nlm.nih.gov/pubmed/17389329?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(287) Hornum L, Romer J, Markholst H. The diabetes-prone BB rat carries a frameshift mutation in Ian4, a positional candidate of Iddm1. diab 2002; 51(6):1972-1979.
PM:12031988
(288) MacMurray AJ, Moralejo DH, Kwitek AE, Rutledge EA, Van Yserloo B, Gohlke P et al. Lymphopenia in the BB Rat Model of Type 1 Diabetes is Due to a Mutation in a Novel Immune-Associated Nucleotide (Ian)-Related Gene. Genome Res 2002; 12(7):1029-1039.
PM:12097339
(289) Hernandez-Hoyos G, Joseph S, Miller NG, Butcher GW. The lymphopenia mutation of the BB rat causes inappropriate apoptosis of mature thymocytes. Eur J Immunol 1999; 29(6):1832-1841.
PM:10382745
(290) Guberski DL, Thomas VA, Shek WR, Like AA, Handler ES, Rossini AA et al. Induction of Type 1 diabetes by Kilham's rat virus in diabetes-resistant BB/Wor rats. Science 1991; 254:1010-1013.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=1658938
(291) Sobel DO, Newsome J, Ewel CH, Bellanti JA, Abbassi V, Creswell K et al. Poly I:C induces development of diabetes mellitus in BB rat. diab 1992; 41(4):515-520.
(292) Like AA. Depletion of RT6.1+ lymphocytes alone is insufficient to induce diabetes in diabetes-resistant BB/WOR rats. Am J Pathol 1990; 136:565-574.
(293) Ramanathan S, Bihoreau MT, Paterson AD, Marandi L, Gauguier D, Poussier P. Thymectomy and radiation-induced type 1 diabetes in nonlymphopenic BB rats. diab 2002; 51(10):2975-2981.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12351436
(294) Ellerman KE, Richards CA, Guberski DL, Shek WR, Like AA. Kilham rat virus triggers T-cell-dependent autoimmune diabetes in multiple strains of rat. diab 1996; 45:557-562.
(295) Chung YH, Jun HS, Son M, Bao M, Bae HY, Kang Y et al. Cellular and molecular mechanism for Kilham rat virus-induced autoimmune diabetes in DR-BB rats. J Immunol 2000; 165(5):2866-2876.
PM:10946320
(296) Zipris D, Lien E, Xie JX, Greiner DL, Mordes JP, Rossini AA. TLR activation synergizes with Kilham rat virus infection to induce diabetes in BBDR rats. J Immunol 2005; 174(1):131-142.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15611235
(297) Hornum L, Lundsgaard D, Markholst H. PolyI:C induction of diabetes is controlled by Iddm4 in rats with a full regulatory T cell pool. Ann N Y Acad Sci 2007; 1110:65-72.:65-72.
(298) Blankenhorn EP, DeScipio C, Rodemich L, Cort L, Leif JH, Greiner DL et al. Refinement of the Iddm4 diabetes susceptibility locus reveals TCRVbeta4 as a candidate gene. Ann N Y Acad Sci 2007; 1103:128-31. Epub@2007 Mar 21.:128-131.
(299) Hornum L, DeScipio C, Markholst H, Troutman SA, Novak S, Leif J et al. Comparative mapping of rat Iddm4 to segments on HSA7 and MMU6. Mamm Genome 2004; 15(1):53-61.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14727142
(300) Kloting I, Schmidt S, Kovacs P. Mapping of novel genes predisposing or protecting diabetes development in the BB/OK rat. Biochem Biophys Res Commun 1998; 245(2):483-486.
PM:9571179
(301) Jackerott M, Hornum L, Andreasen BE, Markholst H. Segregation of autoimmune type 1 diabetes in a cross between diabetic BB and brown Norway rats. J Autoimmun 1997; 10(1):35-41.
PM:9080298
(302) Jackson R, Rassi N, Crump A, Haynes BF, Eisenbarth GS. The BB diabetic rat. Profound T-cell lymphocytopenia. diab 1981; 30(10):887-889.
(303) Ely JM, Greiner DL, Lubaroff DM, Fitch FW. Characterization of monoclonal antibodies that define rat T cell alloantigens. J Immunol 1983; 130:2798-2803.
(304) Greiner DL, Handler ES, Nakano K, Mordes JP, Rossini AA. Absence of the RT-6 T cell subset in diabetes-prone BB/W rats. J Immunol 1986; 136:148-151.
(305) Groen H, Van Der Berk J, Nieuwenhuis P, Kampinga J. Peripheral T cells in diabetes prone (DP) BB rats are CD45R-negative. Thymus 1989; 14:145-150.
(306) Spickett GP, Brandon MR, Mason DW, Williams AF, Woollett GR. MRC OX-22, a monoclonal antibody that labels a new subset of T lymphocytes and reacts with the high molecular weight form of the leukocyte-common antigen. J Exp Med 1983; 158(3):795-810.
PM:6224884
(307) Thomas VA, Woda BA, Handler ES, Greiner DL, Mordes JP, Rossini AA. Altered expression of diabetes in BB/Wor rats by exposure to viral pathogens. diab 1991; 40(2):255-258.
(308) Whalen BJ, Greiner DL, Mordes JP, Rossini AA. Adoptive transfer of autoimmune diabetes mellitus to athymic rats: synergy of CD4+ and CD8+ T cells and prevention by RT6+ T cells. J Autoimmun 1994; 7(6):819-831.
PM:7888038
(309) Rossini AA, Mordes JP, Greiner DL, Nakano K, Appel MC, Handler ES. Spleen cell transfusion in the bio-breeding/worcester rat. J Clin Invest 1986; 77:1399-1401.
(310) Hillebrands JL, Whalen B, Visser JT, Koning J, Bishop KD, Leif J et al. A regulatory CD4+ T cell subset in the BB rat model of autoimmune diabetes expresses neither CD25 nor Foxp3. J Immunol 2006; 177(11):7820-7832.
(311) Holm TL, Lundsgaard D, Markholst H. Characteristics of rat CD4(+)CD25(+) T cells and their ability to prevent not only diabetes but also insulitis in an adoptive transfer model in BB rats. Scand J Immunol 2006; 64(1):17-29.
(312) Georgiou HM, Lagarde AC, Bellgrau D. T cell dysfunction in the diabetes-prone BB rat: a role for thymic migrants that are not T cell precursors. J Exp Med 1988; 167:132-148.
(313) Bellgrau D, Redd JM, Sellins KS. Peculiar T-cell signaling does not preclude positive selection in the diabetes-prone BB rat. diab 1994; 43(1):47-52.
(314) Hosszufalusi N, Chan E, Granger G, Charles MA. Quantitative analyses comparing all major spleen cell phenotypes in BB and normal rats: autoimmune imbalance and double negative T cells associated with resistant, prone and diabetic animals. J Autoimmun 1992; 5(3):305-318.
PM:1388637
(315) Moore JK, Bellgrau D. Promiscuous activation and cell cycle entry in T cells from autoimmune animals. Transplant Proc 1999; 31(3):1606-1610.
PM:10331020
(316) Bieg S, Möller C, Olsson T, Lernmark Å. The lymphopenia (lyp) gene controls the intrathymic cytokine ratio in congenic BioBreeding rats. diabetol 1997; 40:786-792.
(317) Bieg S. Differential expression of p95vav in primary lymphoid tissue of BB rats congenic for the lymphopenia gene. Autoimmunity 1999; 30(1):37-42.
PM:10433093
(318) Zadeh HH, Greiner DL, Wu DY, Tausche F, Goldschneider I. Abnormalities in the export and fate of recent thymic emigrants in diabetes-prone BB/W rats. Autoimmunity 1996; 24(1):35-46.
PM:8937686
(319) Moore JK, Scheinman RI, Bellgrau D. The identification of a novel T cell activation state controlled by a diabetogenic gene. J Immunol 2001; 166(1):241-248.
PM:11123298
(320) Ramanathan S, Norwich K, Poussier P. Antigen activation rescues recent thymic emigrants from programmed cell death in the BB rat. J Immunol 1998; 160(12):5757-5764.
PM:9637485
(321) Delemarre FG, Simons PJ, de Heer HJ, Drexhage HA. Signs of immaturity of splenic dendritic cells from the autoimmune prone biobreeding rat: consequences for the in vitro expansion of regulator and effector T cells. J Immunol 1999; 162(3):1795-1801.
PM:9973444
(322) Delemarre FG, Hoogeveen PG, Haan-Meulman M, Simons PJ, Drexhage HA. Homotypic cluster formation of dendritic cells, a close correlate of their state of maturation. Defects in the biobreeding diabetes-prone rat. J Leukoc Biol 2001; 69(3):373-380.
PM:11261783
(323) Iwakoshi NN, Greiner DL, Rossini AA, Mordes JP. Diabetes prone BB rats are severely deficient in natural killer T cells. Autoimmunity 1999; 31(1):1-14.
PM:10593564
(324) Tullin S, Farris P, Petersen JS, Hornum L, Jackerott M, Markholst H. A pronounced thymic B cell deficiency in the spontaneously diabetic BB rat. J Immunol 1997; 158(11):5554-5559.
PM:9164980
(325) Rozing J, Coolen C, Tielen FJ, Weegenaar J, Schuurman HJ, Greiner DL et al. Defects in the thymic epithelial stroma of diabetes prone BB rats. Thymus 1989; 14(1-3):125-135.
PM:2623736
(326) Bellgrau D, Lagarde A-C. Cytotoxic T-cell precursors with low-level CD8 in the diabetes-prone biobreeding rat: implications for the generation of an autoimmune T-cell repertoire. Proc Natl Acad Sci USA 1990; 87:313-317.
(327) Groen H, Klatter FA, Brons NH, Mesander G, Nieuwenhuis P, Kampinga J. Abnormal thymocyte subset distribution and differential reduction of CD4+ and CD8+ T cell subsets during peripheral maturation in diabetes-prone BioBreeding rats. J Immunol 1996; 156(3):1269-1275.
PM:8558007
(328) Plamondon C, Kottis V, Brideau C, Metroz-Dayer MD, Poussier P. Abnormal thymocyte maturation in spontaneously diabetic BB rats involves the deletion of CD4-8+ cells. J Immunol 1990; 144(3):923-928.
PM:1688592
(329) Whalen BJ, Weiser P, Marounek J, Rossini AA, Mordes JP, Greiner DL. Recapitulation of normal and abnormal BioBreeding rat T cell development in adult thymus organ culture. J Immunol 1999; 162(7):4003-4012.
PM:10201921
(330) McKeever U, Mordes JP, Greiner DL, Appel MC, Rozing J, Handler ES et al. Adoptive transfer of autoimmune diabetes and thyroiditis to athymic rats. Proc Natl Acad Sci U S A 1990; 87(19):7618-7622.
PM:2217193
(331) Sarkar P, Crisa L, McKeever U, Bortell R, Handler E, Mordes JP et al. Loss of RT6 message and most circulating T cells after thymectomy of diabetes prone BB rats. Autoimmunity 1994; 18(1):15-22.
PM:7999952
(332) Jung CG, Kamiyama T, Agui T. Elevated apoptosis of peripheral T lymphocytes in diabetic BB rats. Immunology 1999; 98(4):590-594.
PM:10594693
(333) Crispe IN, Dao T, Klugewitz K, Mehal WZ, Metz DP. The liver as a site of T-cell apoptosis: graveyard, or killing field? Immunol Rev 2000; 174:47-62.
PM:10807506
(334) Scott J. The spontaneously diabetic BB rat: sites of the defects leading to autoimmunity and diabetes mellitus. A review. Curr Top Microbiol Immunol 1990; 156:1-14.
PM:2199161
(335) Francfort JW, Naji A, Silvers WK, Barker CF. The influence of T-lymphocyte precursor cells and thymus grafts on the cellular immunodeficiencies of the BB rat. diab 1985; 34:1134-1138.
(336) Like A, Rossini AA, Guberski DL, Appel MC. Spontaneous diabetes mellitus: Reversal and prevention in the BB/W rat with antiserum to rat lymphocytes. Science 1979; 206:1421-1423.
(337) Like AA, Biron CA, Weringer EJ, Byman K, Sroczynski E, Guberski DL. Prevention of diabetes in BioBreeding/Worcester rats with monoclonal antibodies that recognize T lymphocytes or natural killer cells. J Exp Med 1986; 164(4):1145-1159.
(338) Barlow AK, Like AA. Anti-CD2 monoclonal antibodies prevent spontaneous and adoptive transfer of diabetes in the BB/Wor rat. Am J Pathol 1992; 141(5):1043-1051.
PM:1359788
(339) Like AA, Kislauskis E, Williams RR, Rossini AA. Neonatal thymectomy prevents spontaneous diabetes mellitus in the BB/W rat. Science 1982; 216(4546):644-646.
(340) Murase N, Lieberman I, Nalesnik M, Mintz D, Todo S, Drash AL et al. Prevention of spontaneous diabetes in BB rats with FK 506. Lancet 1990; 336(8711):373-374.
PM:1697397
(341) Nicoletti F, Meroni PL, Barcellini W, Grasso S, Borghi MO, Lunetta M et al. FK-506 prevents diabetes in diabetes-prone BB/Wor rats. Int J Immunopharmacol 1991; 13(7):1027-1030.
PM:1722192
(342) Sadelain MW, Qin HY, Sumoski W, Parfrey N, Singh B, Rabinovitch A. Prevention of diabetes in the BB rat by early immunotherapy using Freund's adjuvant. J Autoimmun 1990; 3(6):671-680.
(343) Like AA, Guberski DL, Butler L. Influence of environmental viral agents on frequency and tempo of diabetes mellitus in BB/Wor rats. diab 1991; 40:259-262.
(344) Dryberg T, Schwimmbeck PL, Oldstone MBA. Inhibition of diabetes in BB rats by virus infection. J Clin Invest 1988; 81:928-931.
(345) Greiner DL, Malkani S, Kanaitsuka T, Bortell R, Doukas J, Rigby M et al. The T cell marker RT6 in a rat model of autoimmune diabetes. Adv Exp Med Biol 1997; 419:209-216.
PM:9193656
(346) Rossini AA, Faustman D, Woda BA, Like AA, Szymanski I, Mordes JP. Lymphocyte transfusions prevent diabetes in the Bio-Breeding/ Worcester rat. J Clin Invest 1984; 74(1):39-46.
(347) Burstein D, Mordes JP, Greiner DL, Stein D, Nakamura N, Handler ES et al. Prevention of diabetes in BB/Wor rat by single transfusion of spleen cells. Parameters that affect degree of protection. diab 1989; 38(1):24-30.
PM:2642432
(348) Ramanathan S, Poussier P. T cell reconstitution of BB/W rats after the initiation of insulitis precipitates the onset of diabetes. J Immunol 1999; 162(9):5134-5142.
PM:10227984
(349) Satoh J, Seino H, Shintani S, Tanaka S, Ohteki T, Masuda T et al. Inhibition of type 1 diabetes in BB rats with recombinant human tumor necrosis factor-alpha. J Immunol 1990; 145(5):1395-1399.
PM:2384663
(350) Whalen BJ, Marounek J, Weiser P, Appel MC, Greiner DL, Mordes JP et al. BB rat thymocytes cultured in the presence of islets lose their ability to transfer autoimmune diabetes. diab 2001; 50(5):972-979.
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11334440
(351) Brugman S, Klatter FA, Visser JT, Wildeboer-Veloo AC, Harmsen HJ, Rozing J et al. Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 2006; 49(9):2105-2108.
(352) Kawano K, Hirashima T, Moris S, Saitoh Y, Kurosumi M, Natori T. New inbred strain of Long-Evans Tokushima lean rats with IDDM without lymphopenia. diab 1991; 40(11):1375-1381.
(353) Yokoi N. Identification of a major gene responsible for type 1 diabetes in the Komeda diabetes-prone rat. Exp Anim 2005; 54(2):111-115.
http://www.ncbi.nlm.nih.gov/pubmed/15897618?ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(354) Yokoi N, Kanazawa M, Kitada K, Tanaka A, Kanazawa Y, Suda S et al. A non-MHC locus essential for autoimmune type I diabetes in the Komeda diabetes-prone rat. J Clin Invest 1997; 100:2015-2021.
(355) Yokoi N, Hayashi C, Fujiwara Y, Wang HY, Seino S. Genetic reconstitution of autoimmune type 1 diabetes with two major susceptibility genes in the rat. Diabetes 2007; 56(2):506-512.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17259398&query_hl=5&itool=pubmed_docsum
(356) Komeda K, Noda M, Terao K, Kuzuya N, Kanazawa M, Kanazawa Y. Establishment of two substrains, diabetes-prone and non-diabetic, from Long-Evans Tokushima Lean (LETL) rats. Endocr J 1998; 45(6):737-744.
PM:10395228
(357) Yokoi N, Komeda K, Wang HY, Yano H, Kitada K, Saitoh Y et al. Cblb is a major susceptibility gene for rat type 1 diabetes mellitus. Nat Genet 2002; 31(4):391-394.
PM:12118252
(358) Kosoy R, Yokoi N, Seino S, Concannon P. Polymorphic variation in the CBLB gene in human type 1 diabetes. Genes Immun 2004; 5(3):232-235.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14961073
(359) Payne F, Smyth DJ, Pask R, Barratt BJ, Cooper JD, Twells RC et al. Haplotype tag single nucleotide polymorphism analysis of the human orthologues of the rat type 1 diabetes genes Ian4 (Lyp/Iddm1) and Cblb. diab 2004; 53(2):505-509.
PM:14747305
(360) Bergholdt R, Taxvig C, Eising S, Nerup J, Pociot F. CBLB variants in type 1 diabetes and their genetic interaction with CTLA4. J Leukoc Biol 2005; 77(4):579-585.
(361) Lenzen S, Tiedge M, Elsner M, Lortz S, Weiss H, Jorns A et al. The LEW.1AR1/Ztm-iddm rat: a new model of spontaneous insulin-dependent diabetes mellitus. diabetol 2001; 44(9):1189-1196.
PM:11596676
(362) Jorns A, Kubat B, Tiedge M, Wedekind D, Hedrich HJ, Kloppel G et al. Pathology of the pancreas and other organs in the diabetic LEW.1AR1/Ztm- iddm rat, a new model of spontaneous insulin-dependent diabetes mellitus. Virchows Arch 2004; 444(2):183-189.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14735361
(363) Jorns A, Gunther A, Hedrich HJ, Wedekind D, Tiedge M, Lenzen S. Immune cell infiltration, cytokine expression, and beta-cell apoptosis during the development of type 1 diabetes in the spontaneously diabetic LEW.1AR1/Ztm-iddm rat. Diabetes 2005; 54(7):2041-2052.
(364) Haskins K, Portas M, Bergman B, Lafferty K, Bradley B. Pancreatic islet-specific T cell clones from nonobese diabetic mice. Proc Natl Acad Sci USA 1989; 86:8000-8004.
(365) Verdaguer J, Yoon J-W, Anderson B, Averill N, Utsugi T, Park B-J et al. Acceleration of spontaneous diabetes in TCR-b-transgenic nonobese diabetic mice by b-cell cytotoxic CD8+ T cells expressing identical endognous TCR-a chains. J Immunol 1996; 157:4726-4735.
(366) Verdaguer J, Schmidt D, Amrani A, Anderson B, Averill N, Santamaria P. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J Exp Med 1997; 186:1663-1676.
(367) Graser RT, DiLorenzo TP, Wang F, Christianson GJ, Chapman HD, Roopenian DC et al. Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions. J Immunol 2000; 164(7):3913-3918.
PM:10725754
(368) Wong FS, Visintin I, Wen L, Flavell RA, Janeway CA. CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J Exp Med 1996; 183:67-76.
(369) Wegmann DR, Shehadeh N, Lafferty KJ, Norbury-Glaser N, Gill RG, Daniel D. Establishment of islet-specific T cell lines and clones from islet isografts placed in spontaneously diabetic NOD mice. J Autoimmun 1993; 6:517-527.
(370) Yang Y, Santamaria P. Dissecting autoimmune diabetes through genetic manipulation of non-obese diabetic mice. diabetol 2003; 46(11):1447-1464.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14586501
(371) Haskins K, Wegmann D. Diabetogenic T-cell clones. diab 1996; 45:1299-1305.
(372) Chaparro RJ, Burton AR, Serreze DV, Vignali DA, DiLorenzo TP. Rapid identification of MHC class I-restricted antigens relevant to autoimmune diabetes using retrogenic T cells. J Immunol Methods 2008; 335(1-2):106-115.
(373) Holst J, Vignali KM, Burton AR, Vignali DA. Rapid analysis of T-cell selection in vivo using T cell-receptor retrogenic mice. Nat Methods 2006; 3(3):191-197.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=16489336&query_hl=7&itool=pubmed_docsum
(374) Holst J, Szymczak-Workman AL, Vignali KM, Burton AR, Workman CJ, Vignali DA. Generation of T-cell receptor retrogenic mice. Nat Protoc 2006; 1(1):406-417.
(375) Arnold PY, Burton AR, Vignali DA. Diabetes incidence is unaltered in glutamate decarboxylase 65-specific TCR retrogenic nonobese diabetic mice: generation by retroviral-mediated stem cell gene transfer. J Immunol 2004; 173(5):3103-3111.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15322170
(376) Lipes MA, Rosenzweig A, Tan KN, Tanigawa G, Ladd D, Seidman JG et al. Progression to diabetes in nonobese diabetic (NOD) mice with transgenic T cell receptors. Science 1993; 259(5098):1165-1169.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8267690
(377) Katz JD, Wang B, Haskins K, Benoist C, Mathis D. Following a diabetogenic T cell from genesis through pathogenesis. Cell 1993; 74:1089-1100.
(378) Shi FD, Flodstrom M, Balasa B, Kim SH, Van Gunst K, Strominger JL et al. Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse. Proc Natl Acad Sci U S A 2001; 98(12):6777-6782.
PM:11390999
(379) Masteller EL, Warner MR, Ferlin W, Judkowski V, Wilson D, Glaichenhaus N et al. Peptide-MHC class II dimers as therapeutics to modulate antigen-specific T cell responses in autoimmune diabetes. J Immunol 2003; 171(10):5587-5595.
http://www.ncbi.nlm.nih.gov/pubmed/14607967?ordinalpos=4&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(380) Jasinski JM, Yu L, Nakayama M, Li MM, Lipes MA, Eisenbarth GS et al. Transgenic insulin (B:9-23) T-cell receptor mice develop autoimmune diabetes dependent upon RAG genotype, H-2g7 homozygosity, and insulin 2 gene knockout. Diabetes 2006; 55(7):1978-1984.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=16804066&query_hl=9&itool=pubmed_docsum
(381) Kanagawa O, Shimizu J, Vaupel BA. Thymic and postthymic regulation of diabetogenic CD8 T cell development in TCR transgenic nonobese diabetic (NOD) mice. J Immunol 2000; 164(10):5466-5473.
PM:10799914
(382) Miller JF, Morahan G, Allison J, Hoffmann M. A transgenic approach to the study of peripheral T-cell tolerance. Immunol Rev 1991; 122:103-116.
PM:1937538
(383) Oldstone MBA, Nerenberg M, Southern P, Price J, Lewicki H. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: Role of anti-self (virus) immune response. Cell 1991; 65:319-331.
(384) Ohashi PS, Oehen S, Buerki K, Pircher H, Ohashi CT, Odermatt B et al. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 1991; 65:305-317.
(385) Apostolou I, von Boehmer H. The TCR-HA, INS-HA transgenic model of autoimmune diabetes: limitations and expectations. J Autoimmun 2004; 22(2):111-114.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14987738
(386) von Herrath MG, Coon B, Lewicki H, Mazarguil H, Gairin JE, Oldstone MB. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes. J Immunol 1998; 161(9):5087-5096.
PM:9794447
(387) Laufer TM, von Herrath MG, Grusby MJ, Oldstone MBA, Glimcher LH. Autoimmune diabetes can be induced in transgenic major histocompatibility complex class II-deficient mice. J Exp Med 1993; 178:589-596.
(388) von Herrath MG, Dockter J, Oldstone MBA. How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. Immunity 1994; 1:231-242.
(389) Lo D, Freedman J, Hesse S, Palmiter RD, Brinster RL, Sherman LA. Peripheral tolerance to an islet cell-specific hemagglutinin transgene affects both CD4+ and CD8+ T cells. Eur J Immunol 1992; 22(4):1013-1022.
PM:1348026
(390) Harlan DM, Hengartner H, Huang ML, Kang YH, Abe R, Moreadith RW et al. Mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness. Proc Natl Acad Sci U S A 1994; 91(8):3137-3141.
PM:7512724
(391) King C, Mueller HR, Malo CM, Murali-Krishna K, Ahmed R, King E et al. Interleukin-4 acts at the locus of the antigen-presenting dendritic cell to counter-regulate cytotoxic CD8+ T-cell responses. Nat Med 2001; 7(2):206-214.
PM:11175852
(392) Apostolou I, Sarukhan A, Klein L, von Boehmer H. Origin of regulatory T cells with known specificity for antigen. Nat Immunol 2002; 3(8):756-763.
PM:12089509
(393) Morgan DJ, Liblau R, Scott B, Fleck S, McDevitt HO, Sarvetnick N et al. CD8(+) T cell-mediated spontaneous diabetes in neonatal mice. J Immunol 1996; 157:978-983.
(394) Vizler C, Bercovici N, Cornet A, Cambouris C, Liblau RS. Role of autoreactive CD8+ T cells in organ-specific autoimmune diseases: insight from transgenic mouse models. Immunol Rev 1999; 169:81-92.
PM:10450510
(395) Degermann S, Reilly C, Scott B, Ogata L, von Boehmer H, Lo D. On the various manifestations of spontaneous autoimmune diabetes in rodent models. Eur J Immunol 1994; 24(12):3155-3160.
PM:7528672
(396) Scott B, Liblau R, Degermann S, Marconi LA, Ogata L, Caton AJ et al. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1994; 1(1):73-83.
PM:7889402
(397) Kurts C, Heath WR, Kosaka H, Miller JF, Carbone FR. The peripheral deletion of autoreactive CD8+ T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1). J Exp Med 1998; 188(2):415-420.
PM:9670055
(398) Blanas E, Carbone FR, Allison J, Miller JF, Heath WR. Induction of autoimmune diabetes by oral administration of autoantigen. Science 1996; 274(5293):1707-1709.
(399) Heath WR, Allison J, Hoffmann MW, Schonrich G, Hammerling G, Arnold B et al. Autoimmune diabetes as a consequence of locally produced interleukin-2. Nature 1992; 359(6395):547-549.
PM:1406974
(400) Lesage S, Hartley S, Wilson JD, Goodnow CC. T cell tolerance in a transgenic mouse model for autoimmune diabetes. Keystone Symposia Regulation of Immunity and Autoimmunity , 115. 2001.
Ref Type: Abstract
(401) Wong FS, Dittel BN, Janeway CAJ. Transgenes and knockout mutations in animal models of type 1 diabetes and multiple sclerosis. Immunol Rev 1999; 169:93-104.
(402) Elias D, Markovits D, Reshef T, Zee R, Cohen IR. Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein. Proc Natl Acad Sci USA 1990; 87:1576-1580.
(403) Renold AE, Soeldner JS, Steinke J. Immunological studies with homologous and heterologous pancreatic insulin in the cow. Ciba Foundation Colloquia on Endocrinology 15, 122-134. 1964. 1964.
Ref Type: Journal (Full)
(404)  Response of calves and heifers to the prolonged administration of porcine and bovine insulin.: 1965.
(405) LeCompte PM, Steinke J, Soeldner JS, Renold AE. Changes in the islets of Langerhans in cows injected with heterologous and homologous insulin. diab 1966; 15(8):586-596.
(406) Renold AE, Steinke J, Soeldner JS, Antomiades HN, Smith RM. Immunological response to the prolonged administration of heterologous and homologous insulin in cattle. J Clin Invest 1966; 45(5):702-713.
(407) Grodsky GM, Feldman R, Toreson WE, Lee JC. Diabetes mellitus in rabbits immunized with insulin. diab 1966; 15:579-585.
(408) Kloppel G, Freytag G. Insulin antibodies and immune insulitis in rabbits immunized with bovine or porcine insulin components. Horm Metab Res 1975; 7:25-30.
(409) Glimcher LH, Schroer JA, Chan C, Shevach EM. Fine specificity of cloned insulin-specific T cell hybridomas: evidence supporting a role for tertiary conformation. J Immunol 1983; 131(6):2868-2874.
PM:6196405
(410) Kahn CR, Rosenthal AS. Immunologic reactions to insulin:  Insulin allergy, insulin resistance, and the autimmune insulin syndrome. Diab care 1979; 2:283-295.
(411) Abiru N, Maniatis AK, Yu L, Miao D, Moriyama H, Wegmann D et al. Peptide and MHC specific breaking of humoral tolerance to native insulin with the B:9-23 peptide in diabetes prone and normal mice. diab 2001; 50:1274-1281.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11375327
(412) Moriyama H, Wen L, Abiru N, Liu E, Yu L, Miao D et al. Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin self-peptide. Proc Natl Acad Sci U S A 2002; 99(8):5539-5544.
(413) Liu E, Abiru N, Moriyama H, Miao D, Eisenbarth GS. Induction of Insulin Autoantibodies and Protection from Diabetes with Subcutaneous Insulin B:9-23 Peptide Without Adjuvant. Annals New York Academy of Sciences 2002; 958:224-227.
(414) Wen L, Peng J, Li Z, Wong FS. The effect of innate immunity on autoimmune diabetes and the expression of toll-like receptors on pancreatic islets. J Immunol 2004; 172(5):3173-3180.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14978124
(415) Liu E, Moriyama H, Abiru N, Paronen J, Devendra D, Finkelman FD et al. Preventing peptide-induced anaphylaxis: addition of C-terminal amino acids to produce a neutral isoelectric point. J Allergy Clin Immunol 2004; 114(3):607-613.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15356565
(416) Liu E, Moriyama H, Abiru N., Miao D, Yu L, Taylor RM et al. Anti-peptide autoantibodies and fatal anaphylaxis in NOD mice in response to insulin self-peptides B:9-23 and B:13-23. J Clin Invest 2002; 110(7):1021-1027.
(417) Devendra D, Jasinski J, Melanitou E, Nakayama M, Li M, Hensley B et al. Interferon-{alpha} as a Mediator of Polyinosinic:Polycytidylic Acid-Induced Type 1 Diabetes. diab 2005; 54(9):2549-2556.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16123342
(418) Graham KL, Sanders N, Tan Y, Allison J, Kay TW, Coulson BS. Rotavirus infection accelerates type 1 diabetes in mice with established insulitis. J Virol 2008; 82(13):6139-6149.
(419) Paronen J, Liu E, Moriyama H, Devendra D, Ide A, Taylor R et al. Genetic differentiation of Poly I : C from B : 9-23 peptide induced experimental autoimmune diabetes. Journal of Autoimmunity 2004; 22(4):307-313.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15120754
(420) von Herrath MG, Guerder S, Lewicki H, Flavell RA, Oldstone MB. Coexpression of B7-1 and viral ("self") transgenes in pancreatic beta cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes. Immunity 1995; 3(6):727-738.
PM:8777718
(421) Pechhold K, Karges W, Blum C, Boehm BO, Harlan DM. Beta cell-specific CD80 (B7-1) expression disrupts tissue protection from autoantigen-specific CTL-mediated diabetes. J Autoimmun 2003; 20(1):1-13.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12604308
(422) Wen L, Chen NY, Tang J, Sherwin R, Wong FS. The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model. J Clin Invest 2001; 107(7):871-880.
PM:11285306
(423) Allison J, Stephens LA, Kay TW, Kurts C, Heath WR, Miller JF et al. The threshold for autoimmune T cell killing is influenced by B7-1. Eur J Immunol 1998; 28(3):949-960.
PM:9541590
(424) Herrera PL, Harlan DM, Fossati L, Izui S, Huarte J, Orci L et al. A CD8+ T-lymphocyte-mediated and CD4+ T-lymphocyte-independent autoimmune diabetes of early onset in transgenic mice. diabetol 1994; 37(12):1277-1279.
PM:7534735
(425) Subudhi SK, Zhou P, Yerian LM, Chin RK, Lo JC, Anders RA et al. Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection. J Clin Invest 2004; 113(5):694-700.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14991067
(426) Serreze DV, Marron MP, DiLorenzo TP. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes. Ann N Y Acad Sci 2007; 1103:103-11. Epub@2007 Mar 21.:103-111.
(427) Macchiarini F, Manz MG, Palucka AK, Shultz LD. Humanized mice: are we there yet? J Exp Med 2005; 202(10):1307-1311.
PM:16301740
(428) Fugger L. Human autoimmunity genes in mice. Curr Opin Immunol 2000; 12(6):698-703.
PM:11102775
(429) Herman AE, Tisch RM, Patel SD, Parry SL, Olson J, Noble JA et al. Determination of glutamic acid decarboxylase 65 peptides presented by the type I diabetes-associated HLA-DQ8 class II molecule identifies an immunogenic peptide motif. J Immunol 1999; 163(11):6275-6282.
(430) Liu J, Purdy LE, Rabinovitch S, Jevnikar AM, Elliott JF. Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice. diab 1999; 48(3):469-477.
(431) Havari E, Lennon-Dumenil AM, Klein L, Neely D, Taylor JA, McInerney MF et al. Expression of the B7.1 costimulatory molecule on pancreatic beta cells abrogates the requirement for CD4 T cells in the development of type 1 diabetes. J Immunol 2004; 173(2):787-796.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15240665
(432) Gebe JA, Unrath KA, Falk BA, Ito K, Wen L, Daniels TL et al. Age-dependent loss of tolerance to an immunodominant epitope of glutamic acid decarboxylase in diabetic-prone RIP-B7/DR4 mice. Clin Immunol 2006; 121(3):294-304.
http://www.ncbi.nlm.nih.gov/pubmed/16979383?ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(433) Gebe JA, Unrath KA, Yue BB, Miyake T, Falk BA, Nepom GT. Autoreactive human T-cell receptor initiates insulitis and impaired glucose tolerance in HLA DR4 transgenic mice. J Autoimmun 2008; 30(4):197-206.
http://www.ncbi.nlm.nih.gov/pubmed/17949947?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(434) Marietta E, Black K, Camilleri M, Krause P, Rogers RS, III, David C et al. A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice. J Clin Invest 2004; 114(8):1090-1097.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15489956
(435) Taneja V, Griffiths M, Behrens M, Luthra HS, David CS. Auricular chondritis in NOD.DQ8.Abetao (Ag7-/-) transgenic mice resembles human relapsing polychondritis. J Clin Invest 2003; 112(12):1843-1850.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14679179
(436) Marron MP, Graser RT, Chapman HD, Serreze DV. Functional evidence for the mediation of diabetogenic T cell responses by HLA-A2.1 MHC class I molecules through transgenic expression in NOD mice. Proceedings of the National Academy of Sciences of the United States of America 2002; 99(21):13753-13758.
(437) Banuelos SJ, Shultz LD, Greiner DL, Burzenski LM, Gott B, Lyons BL et al. Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice. Clin Immunol 2004; 112(3):273-283.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15308121
(438) Jarchum I, Nichol L, Trucco M, Santamaria P, DiLorenzo TP. Identification of novel IGRP epitopes targeted in type 1 diabetes patients. Clin Immunol 2008; 127(3):359-365.
(439) Jarchum I, Baker JC, Yamada T, Takaki T, Marron MP, Serreze DV et al. In vivo cytotoxicity of insulin-specific CD8+ T-cells in HLA-A*0201 transgenic NOD mice. Diabetes 2007; 56(10):2551-2560.
http://www.ncbi.nlm.nih.gov/pubmed/18358785?ordinalpos=5&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
(440) Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S et al. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 2005; 174(10):6477-6489.
http://www.ncbi.nlm.nih.gov/pubmed/17332083?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum1